A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury

References

• Editorial. Traumatic brain injury: time to end the silence. Lancet Neurol 2010;9:331. doi: 10.1016/S1474-4422(10)70069-7.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436–42.
   PubMed Web of Science ®Google Scholar
• Zink BJ. Traumatic brain injury outcome: concepts for emergency care. Ann Emerg Med 2001 Mar;37:318–32.
   PubMed Web of Science ®Google Scholar
• Greenberg MS. Head trauma. In: Handbook of Neurosurgery. 7th ed. New York: Thieme Publications; 2010. p85–929.
   Google Scholar
• Bruns J, Jr, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia 2003;44(Suppl 10):2–10.
   PubMed Web of Science ®Google Scholar
• Health Policy Advisory Committee on Technology. Technology Brief. Biomarkers for the diagnosis and management of traumatic brain injury (TBI). August 2013. Available from: http://www.health.qld.gov.au/healthpact.
   Google Scholar
• Zemlan FP. Antibodies to CSF tau. J Neurochem 1999;73:437–8.
   PubMed Web of Science ®Google Scholar
• Zemlan F, Rosenberg W, Luebbe P, et al. Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J Neurochem 1999;72:741–50.
   PubMed Web of Science ®Google Scholar
• Kovesdi E, Luckl J, Bukovics P, et al. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien) 2010;152:1–17.
   PubMed Web of Science ®Google Scholar
• Liliang PC, Liang CL, Weng HC, et al. Tau proteins in serum predict outcome after severe traumatic brain injury. J Surg Res 2010;160:302–7.
   PubMed Web of Science ®Google Scholar
• Shaw GJ, Jauch EC, Zemlan FP. Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med 2002;39:254–7.
   PubMed Web of Science ®Google Scholar
• Kavalci C, Pekdemir M, Durukan P, et al. The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma. Am J Emerg Med 2007;25:391–5.
   PubMed Web of Science ®Google Scholar
• Gururaj G, Kolluri S. Problems and determinats of traumatic brain injuries in India. Nimhans J 1999;17:407–22.
   Google Scholar
• Odero W, Garner P, Zwi A. Road traffic injuries in developing countries: a comprehensive review of epidemiological studies. Trop Med Int Health 1997;2:445–60.
   PubMed Web of Science ®Google Scholar
• Boucher BA, Hanes SD. Pharmacokinetic alterations after severe head injury. Clinical relevance. Clin Pharmacokinet 1998;35:209–21.
   PubMed Web of Science ®Google Scholar
• Gabbita SP, Scheff SW, Menard RM, et al. Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J Neurotrauma 2005;22:83–94.
   PubMed Web of Science ®Google Scholar
• Ost M, Nylen K, Csajbok L, et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006;67:1600–4.
   PubMed Web of Science ®Google Scholar
• Guzel A, Karasalihoglu S, Aylanc H, et al. Validity of serum tau protein levels in pediatric patients with minor head trauma. Am J Emerg Med 2010 May;28:399–403.
   PubMed Web of Science ®Google Scholar
• Zemlan FP, Jauch EC, Mulchahey JJ, et al. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res 2002;947:131–9.
   PubMed Web of Science ®Google Scholar
• Goedert M, Wischik CM, Crowther RA, et al. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 1998;85:4051–5.
   Web of Science ®Google Scholar
• Kosik KS, Finch EA. MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J Neurosci 1987;7:3142–53.
   PubMed Web of Science ®Google Scholar
• Higuchi M, Lee VM, Trojanowski JQ. Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2002;2:131–50.
   PubMed Web of Science ®Google Scholar
• Chatfield DA, Zemlan FP, Day DJ, Menon DK. Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: a pilot study. Br J Neurosurg 2002;16:471–6.
   PubMed Web of Science ®Google Scholar
• Papa L, Robinson G, Oli M, et al. Use of biomarkers for diagnosis and management of traumatic brain injury patients. Expert Opin Med Diagn 2008;2:937–45.
   PubMedGoogle Scholar